Showing results (191-200 of 1,273) with videos related to
Sort By:
Pageof 128
Clinical Colorectal Cancer|February 11, 2009
Coronary vasospasm with myocardial stunning in a patient with colon cancer receiving adjuvant chemotherapy with FOLFOX regimenJan Cerny, Amr Hassan, Craig Smith, et al.Clinical Colorectal Cancer|September 10, 2009
Pattern of use of adjuvant chemotherapy for stage II colon cancer: a single-institution experienceRaymond U Osarogiagbon, Jasgit C Sachdev, Amna G Khattak, et al.Clinical Colorectal Cancer|September 10, 2009
Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokinesJohn P Mongan, Camilo E Fadul, Bernard F Cole, et al.Clinical Colorectal Cancer|September 10, 2009
Multiplexed cell signaling analysis of metastatic and nonmetastatic colorectal cancer reveals COX2-EGFR signaling activation as a potential prognostic pathway biomarkerMariaelena Pierobon, Valerie Calvert, Claudio Belluco, et al.Clinical Colorectal Cancer|November 28, 2008
Collision tumor of the large bowel in the context of advanced pregnancy and ulcerative colitisAustin Duffy, Jinru Shia, David Klimstra, et al.Clinical Colorectal Cancer|August 16, 2005
Capecitabine/oxaliplatin, a safe and active first-line regimen for older patients with metastatic colorectal cancer: post hoc analysis of a large phase II studyChris J Twelves, Charles A Butts, Jim Cassidy, et al.Clinical Colorectal Cancer|August 16, 2005
Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathwaysScott T Kelley, Domenico Coppola, Timothy Yeatman, et al.Clinical Colorectal Cancer|November 15, 2006
Practical aspects of managing gastrointestinal stromal tumorsStefan Sleijfer, Caroline Seynaeve, Erik Wiemer, et al.Clinical Colorectal Cancer|February 22, 2007
Ribonucleotide reductase subunits M2 and p53R2 are potential biomarkers for metastasis of colon cancerXiyong Liu, Bingsen Zhou, Lijun Xue, et al.Pageof 128